Trial Profile
Effectiveness and Safety of Vildagliptin in Addition to Metformin in Elderly (≥70 years) Greek Patients - the Esteem Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2015
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Vildagliptin/metformin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Esteem
- Sponsors Novartis
- 11 Aug 2015 New trial record